- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Tatva Chintan Pharma Chem Limited has announced a board meeting during which the consolidated financial results for the quarter and nine months ended 31 December 2024 were reviewed and approved. The company reported total income of ₹872.78 Cr, with expenses amounting to ₹807.15 Cr, leading to a profit before tax of ₹65.63 Cr. The profit for the period was recorded at ₹65.63 Cr. These results reflect the company's focus on the specialty chemicals segment, underscoring its operational strength. Future strategies are expected to align with these positive financial outcomes.